Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial looked at radiotherapy to the chest after chemotherapy and rituximab for primary mediastinal large B cell lymphoma.
It was for people who had newly diagnosed lymphoma.
People could join between 2012 and 2019. The team published the main key results in 2024.
Recruitment start: 1 July 2012
Recruitment end: 1 August 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
International Extranodal Lymphoma Study Group (IELSG)
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Southampton Clinical Trials Unit
University Hospital Southampton NHS Foundation Trust
This is Cancer Research UK trial number CRUK/12/040.
Last reviewed: 27 Jul 2026
CRUK internal database number: 10554
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
